Jasper Therapeutics Inc. (JSPR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Operating Expenses | 17,827 | 13,947 | 13,747 | 12,708 | 11,963 |
| Operating Income | -17,827 | -13,947 | -13,747 | -12,708 | -11,963 |
| Other Income | 1,747 | -313 | 536 | 845 | 1,559 |
| Pre-tax Income | -16,080 | -14,260 | -13,211 | -11,863 | -10,404 |
| Net Income Continuous | -16,080 | -14,260 | -13,211 | -11,863 | -10,404 |
| Net Income | $-16,080 | $-14,260 | $-13,211 | $-11,863 | $-10,404 |
| EPS Basic Total Ops | -1.47 | -1.62 | -3.60 | -3.20 | -2.90 |
| EPS Basic Continuous Ops | -1.47 | -1.62 | -3.60 | -3.24 | -2.86 |
| EPS Diluted Total Ops | -1.47 | -1.62 | -3.60 | -3.20 | -2.90 |
| EPS Diluted Continuous Ops | -1.47 | -1.62 | -3.60 | -3.24 | -2.86 |
| EBITDA(a) | $-17,552 | $-13,673 | $-13,474 | $-12,440 | $-11,745 |